Cyclin G2 suppresses estrogen-mediated osteogenesis through inhibition of Wnt/β-catenin signaling

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Gao, Jinlan ^a   Liu, Qi ^a   Liu, Xing ^a   Ji, Chunyan ^a   Qu, Shengqiang ^a   Wang, Shusen ^a   Luo, Yang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; CYCLIN G2; ESTRADIOL; RNA; TRANSCRIPTION FACTOR RUNX2; WNT PROTEIN; ESTROGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN C2C12; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; FEMUR; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MARKER GENE; MESENCHYMAL STEM CELL; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; OVARIECTOMY; PLASMID; PROTEIN EXPRESSION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; C57BL MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; BETA CATENIN; BONE DENSITY; CYCLIN G2; ESTROGENS; FEMALE; MICE; MICE, INBRED C57BL; OSTEOGENESIS; WNT PROTEINS;

EID: 84897099729     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089884     Document Type: Article

References (46)

1. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115: 3318-3325.
2. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377: 1276-1287.
3. Siris ES, Barrett-Connor E, Wehren LE, Berger ML, Sherwood LM (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women - Results from the National Osteoporosis Risk Assessment. Jama-J Am Med Assoc 286: 2815-2822. (Pubitemid 33126923)
4. Spelsberg TC, Riggs BL (1999) The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 13: 819-828. (Pubitemid 30645300)
5. Manolagas SC, Jilka RL (2002) Sex steroids and bone. Recent Prog Horm Res 57: 385-409.
6. Justesen J, Ebbesen EN, Steiniche T (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2: 165-171. (Pubitemid 32851325)
7. Gambacciani M, Cappagli B, Orlandi R (2001) Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas 39: 125-132. (Pubitemid 32769905)
8. Wang Q, Zhai HH, Chen JW, Li DQ, Dong C (2006) Temporal expression of estrogen receptor alpha in rat bone marrow mesenchymal stem cells. Biochem Bioph Res Co 347: 117-123. (Pubitemid 44040908)
9. Masuda H, Takahashi T, Wada M, Itoh R, Eguchi M, et al. (2007) Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 101: 598-606. (Pubitemid 351325877)
10. Zhou S, Wassermann K, Sadovsky Y (2001) Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSC) of osteoporotic mice. Biochem Bioph Res Co 210: 102-123.
11. Waters KM, Riggs BL, Katzenellenbogen JA, Moore J (2001) Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem 83: 448-462. (Pubitemid 33027489)
12. Stossi F, Likhite VS, Katzenellenbogen JA, Katzenellenbogen BS (2006) Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J Biol Chem 281: 16272-16278.
13. Nakamura T, Sasaki YF, Oishi M (1995) Cyclin I: a new cyclin encoded by a gene isolated from human brain. Exp Cell Res 221: 534-542.
14. Bates S, Rowan S, Vousden KH (1996) Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene 13: 1103-1109. (Pubitemid 26329098)
15. Horne MC, Donaldson KL, Goolsby GL, Tran D, Mulheisen M, et al. (1997) Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem 272: 12650-12661. (Pubitemid 27203362)
16. Bennin DA, Don ASA, Brake T, McKenzie JL, Rosenbaum H, et al. (2002) Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G(1)/S phase cell cycle arrest. J Biol Chem 277: 27449-27467. (Pubitemid 34951766)
17. Martinez-Gac L, Marques M, Garcia Z, Campanero MR, Carrera AC (2004) Control of cyclin G2 mRNA expression by forkhead transcription factors: Novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Biol 24: 2181-2189. (Pubitemid 38248955)
18. Gao J, Liu Q, Liu X, Zhang Y, Wang S, et al. (2011) Mutation analysis of the negative regulator cyclin G2 in gastric cancer. Afr J Biotechnol 10: 14618-14624.
19. Liu J, Cui Z-S, Luo Y, Jiang L, Man X-H, et al. (2004) Effect of cyclin G2 on proliferative ability of SGC-7901 cell. World J Gastroentero 10: 1357-1360. (Pubitemid 39162448)
20. Beresford JN, Devlin C, Owen ME (1992) Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 10: 345-350.
21. Aguilar V, Annicotte J-S, Escote X, Vendrell J, Langin D, et al. (2010) Cyclin G2 Regulates Adipogenesis through PPAR gamma Coactivation. Endocrinology 151: 5247-5254.
22. Karsenty G (2001) Minireview: Transcriptional control of osteoblast differentiation. Endocrinology 142: 2731-2733.
23. Aubin JE (1998) Bone stem cells. J Cell Biochem 147: 1531-1537.
24. Babij P, Small C, Yaworsky PJ, Reddy PS, Robinson JA, et al. (2003) High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960-974. (Pubitemid 37294932)
25. Ai M, Van Hul W, Warman ML (2005) Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol Cell Biol 25: 4946-4955. (Pubitemid 40781096)
26. Bodine P, Kharode YP, Lambert AJ, Gaur T, Lian JB (2004) The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 18: 1222-1237. (Pubitemid 38591287)
27. Krishnan V, MacDougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209.
28. Gaur T, Hovhannisyan H, Bodine P, Javed A, Stein JL, et al. (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280: 33132-33140. (Pubitemid 41397109)
29. Ross SE, Longo KA, Lucas PC, MacDougald OA (2000) Inhibition of adipogenesis by Wnt signaling. Science 289: 950-953. (Pubitemid 30659947)
30. Bennett CN, Longo KA, Hemati N, Harrison SD (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277: 30998-31004. (Pubitemid 34970803)
31. Nuttall ME (2000) Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27: 177-184.
32. Kulkarni NH, Zeng QQ, Liu M, Frolik CA, Wei T, et al. (2006) Orally bioavailable GSK-3 alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res 21: 910-920. (Pubitemid 43787998)
33. Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, et al. (2010) Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Mol Cell Endocrinol 325: 118-127.
34. Yu HC, Wu TC, Chen MR, Liu SW, Chen JH, et al. (2010) Mechanical Stretching Induces Osteoprotegerin in Differentiating C2C12 Precursor Cells through Noncanonical Wnt Pathways. J Bone Miner Res 25: 1128-1137.
35. Sowa H, Hendy GN, Komori T, Chihara K (2004) Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem 279: 40267-40275. (Pubitemid 39287610)
36. Gregory CA, Peister A (2004) An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem. 329: 77-84. (Pubitemid 38596903)
37. Kitazawa R, Vannice JL, Pacifici R (1994) Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94: 2397-2406. (Pubitemid 24379614)
38. Rauch F (2004) Osteogenesis imperfecta. Lancet 363: 1377-1385.
39. Riggs BL, Khosla S, Melton LJ 3rd (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13: 763-773. (Pubitemid 28224192)
40. Cadigan KM (1997) Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305.
41. De Boer J, Van Blitterswijk C (2004) Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10: 93-401.
42. Choi M-G, Noh JH, An JY, Hong SK, Park SB, et al. (2009) Expression Levels of Cyclin G2, But Not Cyclin E, Correlate With Gastric Cancer Progression. J Surg Res 157: 168-174.
43. Fu G, Peng C (2011) Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells. Oncogene 30: 3953-3966.
44. Le X-F, Arachchige-Don AS, Mao W, Horne MC, Bast RC Jr (2007) Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells. Mol Cancer Ther 6: 2843-2857. (Pubitemid 350214268)
45. Clements WM, Sarnaik A, MacDonald J, Groden J (2002) beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62: 3503-3506. (Pubitemid 34651399)
46. Howe LR (2004) Wnt signaling and breast cancer. Cancer Biol Ther 3: 36-41.